Neuropharmacological comparison of subcortical actions of anticholinergic compounds.
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001561:Benzilates / Q000494:pharmacology*; D004027:Diencephalon / Q000601:surgery; D005071:Evoked Potentials; D006213:Hallucinogens / Q000494:pharmacology*; D008636:Mesencephalon / Q000187:drug effects / Q000502:physiology*; D009132:Muscles / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology*; D010424:Pentobarbital; D010433:Pentylenetetrazole; D010830:Physostigmine / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D011817:Rabbits; D012154:Reticular Formation / Q000187:drug effects / Q000502:physiology*; D012584:Sciatic Nerve / Q000502:physiology; D012601:Scopolamine / Q000494:pharmacology*; D012640:Seizures / Q000139:chemically induced; D013687:Telencephalon / Q000601:surgery
D001561:Benzilates; D006213:Hallucinogens; D010276:Parasympatholytics; D010880:Piperidines; D001285:Atropine; D010830:Physostigmine; D012601:Scopolamine; D010424:Pentobarbital; D010433:Pentylenetetrazole